|2011||The inaugural issue was released. JPM was published as a quarterly journal.
The first Special Issue “Recent Advances in Personalized Medicine” was announced.
|2013||JPM was indexed in Scopus/SciVerse.|
|2014||JPM was indexed in PubMed and PubMed Central (PMC).|
|2016||JPM announced the first edition of the Travel Awards.|
|2018||JPM was indexed in Emerging Sources Citation Index (ESCI) - Web of Science (Clarivate Analytics).
JPM received CiteScore of 2.62, ranked 54/189 (Q1) in 'Medicine (miscellaneous)'.
|2019||JPM was indexed in Science Citation Index Expanded (SCIE) - Web of Science (Clarivate Analytics), ranked in Q1.|
|2020||JPM received its First Impact Factor (4.433), ranked 10/102(Q1) in the category "Health Care Sciences & Services", 24/165(Q1) in the category "Medicine, General & Internal".|
|2021||JPM adopted a monthly publication schedule.
JPM received 2020 Impact Factor (4.945), ranked 15/108(Q1) in the category " Health Care Sciences & Services", 31/169(Q1) in the category "Medicine, General & Internal".
|2022||JPM received 2021 Impact Factor (3.508), covered in the category " Health Care Sciences & Services" and "Medicine, General & Internal".
JPM organized the first webinar "Radiation Response Biomarkers for Individualised Cancer Treatments".
JPM established the following sections:
-Personalized Therapy and Drug Delivery;
-Evidence Based Medicine;
-Regenerative Medicine and Therapeutics;
-Sex, Gender and Hormone Based Medicine.
|2023||JPM has established the following sections:
-Life Stage Specific Medicine (LSSM);
-Personalized Critical Care;
-Molecular Targeted Therapy.
|2011–2015||Editor-in-Chief: Prof. Dr. Urs A. Meyer|
|2015–2021||Editor-in-Chief: Prof. Dr. Stephen B. Liggett|
|2021–present||Editor-in-Chief: Prof. Dr. David Alan Rizzieri|
|2021–2023||Section Editor-in-Chief: Prof. Dr. Richard E. Frye for the section on Mechanisms of Diseases|
|2021–present||Section Editor-in-Chief: Prof. Dr. Enrico Mini for the section on Pharmacogenetics
Section Editor-in-Chief: Prof. Dr. Kenneth P.H. Pritzker for the section on Clinical Medicine, Cell, and Organism Physiology
Section Editor-in-Chief: Prof. Dr. K. Ray Chaudhuri for the section on Methodology, Drug and Device Discovery
|2022–present||Section Editor-in-Chief: Prof. Dr. Salvatore Scacco for the section on Omics/Informatics
Section Editor-in-Chief: Prof. Dr. Marijn Speeckaert for the section on Epidemiology
Section Editor-in-Chief: Prof. Dr. Liang Cheng for the section on Personalized Therapy and Drug Delivery
Section Editor-in-Chief: Prof. Dr. Taulant Muka for the section on Evidence Based Medicine
|2023–present||Section Editor-in-Chief: Prof. Dr. Anat Biegon for the section on Sex, Gender and Hormone Based Medicine
Section Editor-in-Chief: Prof. Dr. Lorenza Rimassa for the section on Disease Biomarker
Section Editor-in-Chief: Prof. Dr. Weikuan Gu for the section on Life Stage Specific Medicine (LSSM)